Antibiotics vs. Antiviral Agents

At the expense of sounding a bit academic, I must object to the use of the word antibiotic by Donald R. Forsdyke in his commentary1 on the chemotherapy of AIDS. Forsdyke complains that other workers avoid using antibiotic when discussing HIV treatment. Perhaps they know something he doesn't know. An antibiotic is formally defined as a microbial product that kills or inhibits other microbes. AZT and most of the other agents used to treat HIV infections are synthetic molecules. They should rightly

Written byDavid Carlberg
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

At the expense of sounding a bit academic, I must object to the use of the word antibiotic by Donald R. Forsdyke in his commentary1 on the chemotherapy of AIDS. Forsdyke complains that other workers avoid using antibiotic when discussing HIV treatment. Perhaps they know something he doesn't know. An antibiotic is formally defined as a microbial product that kills or inhibits other microbes. AZT and most of the other agents used to treat HIV infections are synthetic molecules. They should rightly be referred to as antiviral agents, antiviral drugs or perhaps antimicrobics, and antibiotic should be reserved for such familiar things as penicillin and streptomycin.

David M. Carlberg, Ph.D.
Professor of Microbiology Emeritus
Department of Biological Sciences
California State University, Long Beach, CA 90840
carlberg@csulb.edu

1. D.R. Forsdyke, "HIV: a grouse-shooting analogy," The Scientist, 14[2]:6, Jan. 24, 2000.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies